About this episode
Just back from IDWeek 2025 in Atlanta, Luis shares the sessions and posters that defined this year's meeting — from next-generation sequencing and diagnostic stewardship to AI in the microbiology lab and new antimicrobials on the horizon.
Tune in for insights on:
-
NGS test utilization and stewardship
-
New β-lactamase inhibitors like nacubactam
-
AI's growing role in clinical microbiology
-
Tedizolid and the importance of optimizing existing agents
🎧 Whether you were in Atlanta or following from afar, this episode captures the energy and innovation of IDWeek — and what it means for the future of diagnostics, stewardship, and patient care.
Resources
Learn more about ID Week : https://idweek.org/
Infectious Diseases Society of America: https://www.idsociety.org/
Stay connected with Let's Talk Micro:
-
Website: letstalkmicro.com
-
Questions or feedback? Email me at [email protected]
Support the podcast:
Get every episode summarized
Each time Let's Talk Micro publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Let's Talk Micro
242: Microbiology & Infection Prevention: Partners in Crime
Let's Talk Micro
241: What Can Whole Genome Sequencing Realistically Tell Us About Resistance?
Let's Talk Micro
240: CLSI M100 2026: Actualizaciones
Let's Talk Micro
239: Inside ASM Microbe 2026
Let's Talk Micro